
Articles
-
3 weeks ago |
psychiatrictimes.com | Grace Koennecke
Preliminary findings from the RESTORE-LIFE study (NCT03320304) show long-term effectiveness of vagus nerve stimulation (VN) in patients with difficult-to-treat depression (DTD). The global, prospective, multi-center, observational study is assessing the long-term effectiveness and safety of VNS as an alternative treatment in patients with DTD.
-
3 weeks ago |
psychiatrictimes.com | Grace Koennecke
MindMed recently announced that the first patient has been dosed in its phase 3 Emerge study evaluating MM120 ODT for treatment of major depressive disorder (MDD). MM120 ODT is a proprietary, pharmaceutically optimized form of lysergic acid diethylamide (LSD). MindMed will also test the efficacy and safety of MM120 ODT 100 µg compared with a placebo, with an expected enrollment of approximately 140 participants in the United States.
-
1 month ago |
psychiatrictimes.com | Grace Koennecke
Findings from a recent online research study by The Harris Poll indicated that clinicians are concerned about their patients’ quality of life as well as medications issues like adherence and switching.
-
1 month ago |
optometrytimes.com | Grace Koennecke
Eyenovia recently announced its entrance into a non-binding letter of intent debating a potential reverse merger transaction with Betaliq, a clinical stage pharmaceutical company with a therapeutic focus on glaucoma. The potential merger would create a new ophthalmic company that pairs two FDA-approved technologies – Betaliq’s EyeSOl water-free drug delivery technology for use in glaucoma and Eyenovia’s Optejet topical ophthalmic liquid dispensing platform.
-
1 month ago |
ophthalmologytimes.com | Grace Koennecke
ZEISS Medical Technology announced the availability of its ZEISS VISULAS Combi, an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp technology in a single, comprehensive solution, in Canada. The treatment is designed for retina, cataract, and glaucoma conditions, streamlining workflow with custom modules, a uniform interface, and space-saving features.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 186
- Tweets
- 1K
- DMs Open
- No

https://t.co/dctf0Pghn6

https://t.co/4r0kpvwMFM

Today, I was so excited to present my senior thesis through the Honors Tutorial College at Ohio University, titled "Exploring the Last 25 Years of Hip-Hop and its Implications." https://t.co/tWjoCq1Fnl